ZMapp: New Medication for Ebola Virus Disease
Two U.S. missionaries tending to the sick became infected; the missionary group and the infected patients volunteered to use an experimental drug, untried in any humans, in an attempt to save the missionaries, a doctor and an aid worker. The new drug given to them is uniquely designed to allow the human body to win against Ebola replication.
This new drug, termed ZMapp, was developed by a biotech firm (Mapp Biopharmaceutical, Inc.). Several years ago, this company and the National Institutes of Health and the Defense Threat Reduction Agency were tasked to develop a treatment for Ebola virus infection.